In other words, neither Ozempic nor Mounjaro is likely to be covered for weight loss, but they could both be covered for Type 2 diabetes, because they are FDA approved for that use
The effect of GLP-1R agonists liraglutide and exendin-4 was examined in vitro on LOVO, CA-77, MCF-7, MDA-MB-231, KPL-1, MB-468, 4TI, BT483, ZR751, LNCap, PC3, ALVA-41, DU145, LNCap, PANC-1, MiaPaCa-2, PANC, CT26, SKOV3, OVCAR3, OVCAR4, A2780, and ES-2 cell lines that are expressed in several cancers including colorectal, pancreatic, thyroid, breast, prostate, ovarian, and colon (Table 1)
Any dose you see online is based on preliminary trials, not an FDA-approved dose
Someone starting at 300 pounds with significant insulin resistance may lose 12 pounds in the first month